サマリー

Opioid Drugs can act on the pain central system in the human brain, brainstem and other tissues, thus exerting a strong downward pain suppression effect.
Opioid Drugs can not only bind to peripheral nerve opioid receptors, but also to opioid receptors in the gelatinous (second layer) sensory neurons of the spinal dorsal horn in the human body, and can also inhibit the Released, effectively preventing pain sensations from flowing into the brain.

Market Analysis and Insights: Global Opioid Drugs Market
The global Opioid Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Opioid Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Opioid Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Opioid Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Opioid Drugs market.

Global Opioid Drugs Scope and Market Size
Opioid Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Opioid Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Buprenorphine
Fentanyl
Hydrocodone
Morphine
Oxycodone
Tramadol
Others

Segment by Application
Anesthesia
Pain relief
Cough suppression
Diarrhea suppression
Deaddiction
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Acura Pharmaceuticals
Cipher Pharmaceutical Inc.
Daiichi Sankyo
Johnson＆Johnson
Lupin Limited
Pfizer
Sun Pharmaceuticals
Teva Pharmaceutical Industries Ltd.

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Opioid Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Buprenorphine
1.2.3 Fentanyl
1.2.4 Hydrocodone
1.2.5 Morphine
1.2.6 Oxycodone
1.2.7 Tramadol
1.2.8 Others
1.3 Market by Application
1.3.1 Global Opioid Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Anesthesia
1.3.3 Pain relief
1.3.4 Cough suppression
1.3.5 Diarrhea suppression
1.3.6 Deaddiction
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Opioid Drugs Market Perspective (2016-2027)
2.2 Opioid Drugs Growth Trends by Regions
2.2.1 Opioid Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Opioid Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Opioid Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Opioid Drugs Industry Dynamic
2.3.1 Opioid Drugs Market Trends
2.3.2 Opioid Drugs Market Drivers
2.3.3 Opioid Drugs Market Challenges
2.3.4 Opioid Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Opioid Drugs Players by Revenue
3.1.1 Global Top Opioid Drugs Players by Revenue (2016-2021)
3.1.2 Global Opioid Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Opioid Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Opioid Drugs Revenue
3.4 Global Opioid Drugs Market Concentration Ratio
3.4.1 Global Opioid Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Opioid Drugs Revenue in 2020
3.5 Opioid Drugs Key Players Head office and Area Served
3.6 Key Players Opioid Drugs Product Solution and Service
3.7 Date of Enter into Opioid Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Opioid Drugs Breakdown Data by Type
4.1 Global Opioid Drugs Historic Market Size by Type (2016-2021)
4.2 Global Opioid Drugs Forecasted Market Size by Type (2022-2027)

5 Opioid Drugs Breakdown Data by Application
5.1 Global Opioid Drugs Historic Market Size by Application (2016-2021)
5.2 Global Opioid Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Opioid Drugs Market Size (2016-2027)
6.2 North America Opioid Drugs Market Size by Type
6.2.1 North America Opioid Drugs Market Size by Type (2016-2021)
6.2.2 North America Opioid Drugs Market Size by Type (2022-2027)
6.2.3 North America Opioid Drugs Market Size by Type (2016-2027)
6.3 North America Opioid Drugs Market Size by Application
6.3.1 North America Opioid Drugs Market Size by Application (2016-2021)
6.3.2 North America Opioid Drugs Market Size by Application (2022-2027)
6.3.3 North America Opioid Drugs Market Size by Application (2016-2027)
6.4 North America Opioid Drugs Market Size by Country
6.4.1 North America Opioid Drugs Market Size by Country (2016-2021)
6.4.2 North America Opioid Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Opioid Drugs Market Size (2016-2027)
7.2 Europe Opioid Drugs Market Size by Type
7.2.1 Europe Opioid Drugs Market Size by Type (2016-2021)
7.2.2 Europe Opioid Drugs Market Size by Type (2022-2027)
7.2.3 Europe Opioid Drugs Market Size by Type (2016-2027)
7.3 Europe Opioid Drugs Market Size by Application
7.3.1 Europe Opioid Drugs Market Size by Application (2016-2021)
7.3.2 Europe Opioid Drugs Market Size by Application (2022-2027)
7.3.3 Europe Opioid Drugs Market Size by Application (2016-2027)
7.4 Europe Opioid Drugs Market Size by Country
7.4.1 Europe Opioid Drugs Market Size by Country (2016-2021)
7.4.2 Europe Opioid Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Opioid Drugs Market Size (2016-2027)
8.2 Asia-Pacific Opioid Drugs Market Size by Type
8.2.1 Asia-Pacific Opioid Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Opioid Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Opioid Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Opioid Drugs Market Size by Application
8.3.1 Asia-Pacific Opioid Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Opioid Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Opioid Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Opioid Drugs Market Size by Region
8.4.1 Asia-Pacific Opioid Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Opioid Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Opioid Drugs Market Size (2016-2027)
9.2 Latin America Opioid Drugs Market Size by Type
9.2.1 Latin America Opioid Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Opioid Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Opioid Drugs Market Size by Type (2016-2027)
9.3 Latin America Opioid Drugs Market Size by Application
9.3.1 Latin America Opioid Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Opioid Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Opioid Drugs Market Size by Application (2016-2027)
9.4 Latin America Opioid Drugs Market Size by Country
9.4.1 Latin America Opioid Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Opioid Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Opioid Drugs Market Size (2016-2027)
10.2 Middle East & Africa Opioid Drugs Market Size by Type
10.2.1 Middle East & Africa Opioid Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Opioid Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Opioid Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Opioid Drugs Market Size by Application
10.3.1 Middle East & Africa Opioid Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Opioid Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Opioid Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Opioid Drugs Market Size by Country
10.4.1 Middle East & Africa Opioid Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Opioid Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Acura Pharmaceuticals
11.1.1 Acura Pharmaceuticals Company Details
11.1.2 Acura Pharmaceuticals Business Overview
11.1.3 Acura Pharmaceuticals Opioid Drugs Introduction
11.1.4 Acura Pharmaceuticals Revenue in Opioid Drugs Business (2016-2021)
11.1.5 Acura Pharmaceuticals Recent Development
11.2 Cipher Pharmaceutical Inc.
11.2.1 Cipher Pharmaceutical Inc. Company Details
11.2.2 Cipher Pharmaceutical Inc. Business Overview
11.2.3 Cipher Pharmaceutical Inc. Opioid Drugs Introduction
11.2.4 Cipher Pharmaceutical Inc. Revenue in Opioid Drugs Business (2016-2021)
11.2.5 Cipher Pharmaceutical Inc. Recent Development
11.3 Daiichi Sankyo
11.3.1 Daiichi Sankyo Company Details
11.3.2 Daiichi Sankyo Business Overview
11.3.3 Daiichi Sankyo Opioid Drugs Introduction
11.3.4 Daiichi Sankyo Revenue in Opioid Drugs Business (2016-2021)
11.3.5 Daiichi Sankyo Recent Development
11.4 Johnson＆Johnson
11.4.1 Johnson＆Johnson Company Details
11.4.2 Johnson＆Johnson Business Overview
11.4.3 Johnson＆Johnson Opioid Drugs Introduction
11.4.4 Johnson＆Johnson Revenue in Opioid Drugs Business (2016-2021)
11.4.5 Johnson＆Johnson Recent Development
11.5 Lupin Limited
11.5.1 Lupin Limited Company Details
11.5.2 Lupin Limited Business Overview
11.5.3 Lupin Limited Opioid Drugs Introduction
11.5.4 Lupin Limited Revenue in Opioid Drugs Business (2016-2021)
11.5.5 Lupin Limited Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Opioid Drugs Introduction
11.6.4 Pfizer Revenue in Opioid Drugs Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Sun Pharmaceuticals
11.7.1 Sun Pharmaceuticals Company Details
11.7.2 Sun Pharmaceuticals Business Overview
11.7.3 Sun Pharmaceuticals Opioid Drugs Introduction
11.7.4 Sun Pharmaceuticals Revenue in Opioid Drugs Business (2016-2021)
11.7.5 Sun Pharmaceuticals Recent Development
11.8 Teva Pharmaceutical Industries Ltd.
11.8.1 Teva Pharmaceutical Industries Ltd. Company Details
11.8.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.8.3 Teva Pharmaceutical Industries Ltd. Opioid Drugs Introduction
11.8.4 Teva Pharmaceutical Industries Ltd. Revenue in Opioid Drugs Business (2016-2021)
11.8.5 Teva Pharmaceutical Industries Ltd. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details